AMRUTANJAN HEALTH CARE
|
AMRUTANJAN HEALTH CARE Last 5 Year Financial Ratios History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 20.03 | 17.58 | 15.56 | 13.63 | 22.99 |
| CEPS(Rs) | 22.22 | 19.84 | 17.65 | 15.41 | 24.28 |
| DPS(Rs) | 4.90 | 4.60 | 4.60 | 4.60 | 4.60 |
| Book NAV/Share(Rs) | 128.27 | 112.83 | 99.92 | 99.12 | 90.49 |
| Tax Rate(%) | 25.64 | 26.47 | 27.40 | 25.74 | 25.82 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 15.09 | 12.91 | 12.32 | 11.73 | 19.11 |
| EBIT Margin(%) | 15.57 | 15.37 | 14.77 | 14.19 | 22.46 |
| Pre Tax Margin(%) | 15.50 | 15.30 | 14.71 | 14.13 | 22.32 |
| PAT Margin (%) | 11.52 | 11.25 | 10.68 | 10.49 | 16.56 |
| Cash Profit Margin (%) | 12.78 | 12.70 | 12.11 | 11.87 | 17.49 |
| Performance Ratios | |||||
| ROA(%) | 12.57 | 13.00 | 12.47 | 11.32 | 21.78 |
| ROE(%) | 16.62 | 16.53 | 15.54 | 14.37 | 28.03 |
| ROCE(%) | 22.46 | 22.58 | 21.47 | 19.38 | 37.93 |
| Asset Turnover(x) | 1.09 | 1.16 | 1.17 | 1.08 | 1.32 |
| Sales/Fixed Asset(x) | 5.89 | 5.73 | 5.63 | 6.26 | 9.31 |
| Working Capital/Sales(x) | 3.04 | 2.19 | 1.87 | 1.93 | 2.06 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.17 | 0.17 | 0.18 | 0.16 | 0.11 |
| Receivable days | 42.29 | 41.89 | 35.05 | 34.26 | 25.15 |
| Inventory Days | 23.46 | 22.69 | 25.01 | 26.36 | 19.54 |
| Payable days | 104.51 | 102.13 | 89.00 | 108.19 | 102.26 |
| Valuation Parameters | |||||
| PER(x) | 24.70 | 36.67 | 39.77 | 42.19 | 34.53 |
| PCE(x) | 22.27 | 32.50 | 35.05 | 37.31 | 32.69 |
| Price/Book(x) | 3.86 | 5.72 | 6.19 | 5.80 | 8.77 |
| Yield(%) | 0.99 | 0.71 | 0.74 | 0.80 | 0.58 |
| EV/Net Sales(x) | 2.78 | 3.94 | 4.18 | 4.24 | 5.50 |
| EV/Core EBITDA(x) | 14.96 | 23.44 | 25.81 | 27.26 | 23.51 |
| EV/EBIT(x) | 17.86 | 25.64 | 28.33 | 29.89 | 24.49 |
| EV/CE(x) | 3.77 | 5.45 | 6.11 | 5.54 | 6.45 |
| M Cap / Sales | 2.85 | 4.13 | 4.25 | 4.43 | 5.72 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 11.23 | 7.26 | 10.96 | -6.46 | 21.93 |
| Core EBITDA Growth(%) | 22.96 | 11.33 | 15.53 | -37.78 | 10.20 |
| EBIT Growth(%) | 12.66 | 11.68 | 15.46 | -40.91 | 10.50 |
| PAT Growth(%) | 13.93 | 13.03 | 12.90 | -40.71 | 9.80 |
| EPS Growth(%) | 13.93 | 13.04 | 14.15 | -40.71 | 9.80 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 2.31 | 3.44 | 4.23 | 4.13 | 3.55 |
| Quick Ratio(x) | 2.02 | 3.11 | 3.82 | 3.67 | 3.21 |
| Interest Cover(x) | 212.94 | 213.00 | 247.90 | 241.99 | 156.66 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of AMRUTANJAN HEALTH CARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMRUTANJAN HEALTH CARE | ₹1,484.9 Cr | 1.5% | 3% | -30.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
AMRUTANJAN HEALTH CARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMRUTANJAN HEALTH CARE | 1.5% |
3% |
-30.3% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses
